DE2113123A1 - Verfahren zur Herstellung von Viruspartikeln oder doppelstraengiger Ribonucleinsaeure - Google Patents
Verfahren zur Herstellung von Viruspartikeln oder doppelstraengiger RibonucleinsaeureInfo
- Publication number
- DE2113123A1 DE2113123A1 DE19712113123 DE2113123A DE2113123A1 DE 2113123 A1 DE2113123 A1 DE 2113123A1 DE 19712113123 DE19712113123 DE 19712113123 DE 2113123 A DE2113123 A DE 2113123A DE 2113123 A1 DE2113123 A1 DE 2113123A1
- Authority
- DE
- Germany
- Prior art keywords
- ribonucleic acid
- virus particles
- double
- salt
- stranded ribonucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 title claims description 47
- 239000002245 particle Substances 0.000 title claims description 41
- 229920002477 rna polymer Polymers 0.000 title claims description 32
- 238000000034 method Methods 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 230000008569 process Effects 0.000 title claims description 7
- 239000001963 growth medium Substances 0.000 claims description 13
- 241000892910 Aspergillus foetidus Species 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 241000228245 Aspergillus niger Species 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 238000001085 differential centrifugation Methods 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 claims 1
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 102000014150 Interferons Human genes 0.000 description 5
- 108010050904 Interferons Proteins 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229940079322 interferon Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000014676 Phragmites communis Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 239000010871 livestock manure Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 241000228145 Penicillium brevicompactum Species 0.000 description 2
- 241000228150 Penicillium chrysogenum Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001136494 Talaromyces funiculosus Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000001738 isopycnic centrifugation Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 229930183912 Cytidylic acid Natural products 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 238000001286 analytical centrifugation Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB03826/70A GB1300259A (en) | 1970-03-23 | 1970-03-23 | Biologically active material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2113123A1 true DE2113123A1 (de) | 1971-10-14 |
Family
ID=10030078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712113123 Pending DE2113123A1 (de) | 1970-03-23 | 1971-03-18 | Verfahren zur Herstellung von Viruspartikeln oder doppelstraengiger Ribonucleinsaeure |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE764715A (enExample) |
| DE (1) | DE2113123A1 (enExample) |
| ES (1) | ES389437A1 (enExample) |
| FR (1) | FR2085729B1 (enExample) |
| GB (1) | GB1300259A (enExample) |
| IL (1) | IL36388A0 (enExample) |
| NL (1) | NL7103768A (enExample) |
| ZA (1) | ZA711813B (enExample) |
-
1970
- 1970-03-23 GB GB03826/70A patent/GB1300259A/en not_active Expired
-
1971
- 1971-03-10 IL IL36388A patent/IL36388A0/xx unknown
- 1971-03-18 DE DE19712113123 patent/DE2113123A1/de active Pending
- 1971-03-19 NL NL7103768A patent/NL7103768A/xx unknown
- 1971-03-19 ZA ZA711813A patent/ZA711813B/xx unknown
- 1971-03-22 ES ES389437A patent/ES389437A1/es not_active Expired
- 1971-03-22 FR FR7109918A patent/FR2085729B1/fr not_active Expired
- 1971-03-23 BE BE764715A patent/BE764715A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA711813B (en) | 1971-12-29 |
| NL7103768A (enExample) | 1971-09-27 |
| ES389437A1 (es) | 1974-03-16 |
| GB1300259A (en) | 1972-12-20 |
| IL36388A0 (en) | 1971-05-26 |
| FR2085729B1 (enExample) | 1974-08-02 |
| FR2085729A1 (enExample) | 1971-12-31 |
| BE764715A (fr) | 1971-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2524355A1 (de) | Physiologisch aktive verbindungen und verfahren zu ihrer herstellung | |
| DE2731570C3 (de) | Verfahren zur Gewinnung eines Polysaccharide mit therapeutischer Wirkung | |
| DE3448153C2 (enExample) | ||
| DE3109335C2 (de) | Ebelacton A und B, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel | |
| DE3304468A1 (de) | Mikroorganismenzellen die s-adenosylmethionin enthalten verfahren zu deren herstellung | |
| DE2939269C2 (de) | Verfahren zur optischen Trennung von DL-2-Amino-4-hydroxy(methyl)phosphinoylbuttersäure | |
| DE1617397C3 (de) | Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus | |
| DE2028403C3 (de) | Pepstatin | |
| DE1949719C2 (de) | Mikrobiologische Herstellung von Dextranase | |
| DE69810024T2 (de) | Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten | |
| DE2113123A1 (de) | Verfahren zur Herstellung von Viruspartikeln oder doppelstraengiger Ribonucleinsaeure | |
| DE3031152C2 (enExample) | ||
| DE2921829C2 (enExample) | ||
| AT350716B (de) | Verfahren zur herstellung neuer antibiotika | |
| DE2209018A1 (de) | Neues Antibioticum A-4696 | |
| DE1717100C (de) | Verfahren zur Herstellung von Prapara ten hamolytischer Streptococcen zur unter stutzenden Behandlung von Carcinomerkrankun gen | |
| DE939397C (de) | Verfahren zur Herstellung und Gewinnung eines Produktes mit antiviraler Aktivitaet | |
| CH651052A5 (de) | Verfahren zur herstellung einer karzinostatischen substanz und karzinostatische substanz. | |
| DE2239210B2 (de) | Verfahren zur Herstellung von a- Galactosidase, die eine starke a- Galactosidase-Aktivität und eine äußerst geringe Invertase-Aktivität aufweist, und deren Verwendung zur Zerlegung von Raffinose | |
| DE1492137C (de) | Verfahren zur Herstellung von Oxy tetracyclin auf biologischem Weg | |
| DE3213080A1 (de) | Neuer fusarium lateritium-stamm und dessen verwendung zur herstellung von antibiotika | |
| CH666482A5 (de) | Metabolit, dessen herstellung und verwendung. | |
| DE1467883A1 (de) | Neues Antibiotikum,Verfahren zu dessen Herstellung und dreses Antibiotikum enthaltendes Tierfutter | |
| DE2030101A1 (de) | Verfahren zur Gewinnung einer Ribonucleinsäure aus Viren und ihrer nicht-toxischen Salze | |
| DE1935667A1 (de) | Verfahren zur Herstellung von Interferon erzeugenden Mitteln |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |